Valuation: Aprogen Medicines Inc.

Market Cap	48.6B 33.81M 29.39M 27.36M 25.12M 47.43M 3.23B 48.17M 322M 127M 1.61B 127M 124M 5.39B	P/E 2024	-3.44x	P/E 2025	-2.95x
Enterprise Value	186B 129M 112M 105M 95.98M 181M 12.33B 184M 1.23B 484M 6.14B 485M 475M 20.59B	EV / Sales 2024	1.93x	EV / Sales 2025	2.99x
Free-Float	79.55%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Aprogen Medicines Inc.

07-27	Aprogen Biologics Inc. announced that it has received KRW 2.000000772 billion in funding from Aprogen Medicines Inc.	CI
07-23	Aprogen Medicines Inc. announced that it has received KRW 2 billion in funding	CI
07-14	Aprogen Medicines to Raise 2 Billion Won Through Convertible Bond Issue	MT
07-14	Aprogen Biologics Inc. announced that it expects to receive KRW 2.000000772 billion in funding from Aprogen Medicines Inc.	CI
07-13	Aprogen Medicines Inc. announced that it expects to receive KRW 2 billion in funding	CI
05-29	Aprogen Medicines Inc. announced that it has received KRW 10 billion in funding from N2Tech Co.,Ltd	CI
05-20	APTN Inc. announced that it has received KRW 122.600000101 billion in funding from Aprogen, Inc., Aprogen Medicines Inc., Aprogen Pharma Inc. and other investors.	CI
05-15	Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-08	Aprogen Medicines Inc. announced that it has received KRW 12 billion in funding from APTOCROM Inc.	CI
04-28	Aprogen Medicines Inc. announced that it expects to receive KRW 12 billion in funding from APTOCROM Inc.	CI
04-17	Aprogen Medicines Inc. announced that it has received KRW 2.00000351 billion in funding from G-Baise Inc.	CI
04-02	Aprogen Medicines Inc. announced that it expects to receive KRW 2.00000351 billion in funding from G-Baise Inc.	CI
03-23	Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

More news

Managers and Directors: Aprogen Medicines Inc.

Manager	Title	Age	Since
Jae-Seob Kim CEO	Chief Executive Officer	63	27/12/2017
Hak-Ju Kim AUD	Comptroller/Controller/Auditor	69	28/03/2018

Director	Title	Age	Since
Jae-Seob Kim BRD	Director/Board Member	63	29/11/2022
Hyeon-Su Lee BRD	Director/Board Member	64	18/07/2022
Yun-Gyeong Bae BRD	Director/Board Member	62	13/10/2023

More insiders

Aprogen Inc, formerly Aprogen Medicines Inc, is a Korea-based company mainly engaged in the business of hardfacing. The Company operates its business through six segments. The Hardfacing segment is engaged in the provision of hardfacing for maintenance of steel mills, thermal power plants and cement plants. The Steel Sale segment is engaged in the sale of steel products, aluminum ingots and others. The Insulation segment is engaged in the nuclear thermal insulation and insulation construction. The Pharmaceutical segment is engaged in the manufacture and sale of pharmaceuticals. The Game segment is engaged in the mobile game publishing business. The Other segment is engaged in the sale of scrap metal.

Employees

253

Sector

Industrial Machinery & Equipment

More about the company

Quotes

Date	Price	Change	Volume
31/07/26	₩2,310.00	+10.00%	116,637
30/07/26	₩2,100.00	-2.10%	78,353
29/07/26	₩2,145.00	-1.38%	218,685
28/07/26	₩2,175.00	-6.05%	117,043
27/07/26	₩2,315.00	+2.21%	65,198

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Korea S.E. Other stock markets 31/07/2026			5-day change	1st Jan Change
2,310.00 ^KRW	+10.00%		0.00%	-77.91%

1 day	+10.00%
Current month	-7.60%
1 month	-7.60%
3 months	-47.44%
6 months	-79.10%
Current year	-77.91%

1 week	1,961	2,400
1 month	1,961	2,630
Current year	1,961	11,880
1 year	1,961	14,070
3 years	1,961	47,775
5 years	1,961	110,250
10 years	1,961	875,250

Date	Insider	Type	Quantity	% Market Cap.
17/01/25	Yong-tae Kim	Others	7,673	0.0025%
19/01/24	Young-Suk Yeom	Free	101,429	0.0383%
19/01/24	Seon-joo Kang	Free	198,187	0.0748%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
APROGEN MEDICINES INC.	+10.00%	0.00%	-75.08%	-89.73%	30.93M
LINCOLN ELECTRIC HOLDINGS, INC.	+4.49%	+4.01%	+7.42%	+30.32%	13.71B
HAN'S LASER TECHNOLOGY INDUSTRY GROUP CO., LTD.	+3.19%	-19.74%	+218.79%	+245.08%	12.47B
ESAB CORPORATION	+2.72%	+4.33%	-34.34%	+28.24%	5.32B
WUHAN RAYCUS FIBER LASER TECHNOLOGIES CO., LTD.	+5.57%	-6.68%	+6.21%	+10.18%	2.5B
SBT ULTRASONIC TECHNOLOGY CO., LTD.	+5.54%	-17.74%	+72.77%	+49.32%	2B
INNO LASER TECHNOLOGY CO., LTD.	+3.45%	-19.01%	+70.76%	+121.86%	1.16B
SHENZHEN UNITED WINNERS LASER CO., LTD.	+1.76%	+2.50%	-16.09%	-23.05%	916M
ESAB INDIA LIMITED	+0.71%	-1.69%	+4.02%	+16.58%	901M
SHANGHAI HUGONG ELECTRIC GROUP CO.,LTD.	+2.64%	+1.84%	-20.97%	+9.12%	697M
Average	+4.00%	-5.09%	+23.35%	+39.79%	3.97B
Weighted average by Cap.	+3.73%	-4.69%	+72.09%	+97.83%

Aprogen Medicines Inc. Stock

Stocks

A007460

KR7007460009

Industrial Machinery & Equipment

Valuation: Aprogen Medicines Inc.

Chart: Aprogen Medicines Inc.

Latest news : Aprogen Medicines Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Aprogen Medicines Inc.

Latest insider transactions

Welding & Soldering Equipment

Financials

Company Profile

Quotes

Income Statement and Estimates

	2024	2025
Net sales	150B 104M 90.79M 84.5M 77.58M 147M 9.97B 149M 996M 391M 4.96B 392M 384M 16.64B	118B 82.08M 71.35M 66.41M 60.97M 115M 7.84B 117M 783M 307M 3.9B 308M 301M 13.08B
Net income	-58.08B -40.41M -35.13M -32.69M -30.02M -56.69M -3.86B -57.56M -385M -151M -1.92B -152M -148M -6.44B	-70.2B -48.84M -42.46M -39.52M -36.28M -68.52M -4.66B -69.58M -466M -183M -2.32B -183M -179M -7.78B
Net Debt	70.04B 48.73M 42.36M 39.43M 36.2M 68.36M 4.65B 69.42M 465M 182M 2.32B 183M 179M 7.77B	137B 95.39M 82.92M 77.18M 70.86M 134M 9.11B 136M 910M 357M 4.53B 358M 350M 15.2B